Value Bridge — LEXINGTON MEDICAL CENTER
Current $16M → Target $48M (+$31.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$16.3M
Current EBITDA
$48.0M
Target EBITDA
+$31.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.2M
Payer Mix Optimization
$17.2M
Cost to Collect Reduction
$5.7M
Clean Claim Improvement
$4.3M
Volume & Rate Growth
$28.6M
What This Means
The 7-lever model projects a 194% EBITDA uplift from $16M to $48M. The highest-impact lever is Volume & Rate Growth at $11.5M probability-weighted.
IC talking point: "We see $32M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $348M in equity value creation."